Interpreting new molecular genetics in myelodysplastic syndromes.

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn 2012, Issue , 2012, Pages 56-64

  Abdel Wahab, Omar ^a   Figueroa, Maria E ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASXL1 PROTEIN, HUMAN; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA BINDING PROTEIN; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 3A; EZH2 PROTEIN, HUMAN; HISTONE; IDH1 PROTEIN, HUMAN; ISOCITRATE DEHYDROGENASE; ISOCITRATE DEHYDROGENASE 2, HUMAN; MESSENGER RNA; ONCOPROTEIN; POLYCOMB REPRESSIVE COMPLEX 2; REPRESSOR PROTEIN; TET2 PROTEIN, HUMAN;

ALLELE; BIOLOGICAL MODEL; CHROMOSOME ABERRATION; DISEASE COURSE; DRUG ANTAGONISM; GENETIC EPIGENESIS; GENETICS; HEMATOPOIESIS; HUMAN; METABOLISM; MUTATION; MYELODYSPLASTIC SYNDROME; REVIEW; TREATMENT OUTCOME;

ALLELES; CHROMOSOME ABERRATIONS; DISEASE PROGRESSION; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA MODIFICATION METHYLASES; DNA-BINDING PROTEINS; EPIGENESIS, GENETIC; HEMATOPOIESIS; HISTONES; HUMANS; ISOCITRATE DEHYDROGENASE; MODELS, GENETIC; MUTATION; MYELODYSPLASTIC SYNDROMES; POLYCOMB REPRESSIVE COMPLEX 2; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; RNA, MESSENGER; TREATMENT OUTCOME;

EID: 84878328784     PISSN: None     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation.v2012.1.56.3798194     Document Type: Review

References (0)